HomeNXTCL • STO
add
NextCell Pharma AB
Previous close
kr 2.96
Day range
kr 2.96 - kr 3.26
Year range
kr 1.16 - kr 4.03
Market cap
238.28M SEK
Avg Volume
465.94K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Nov 2024info | Y/Y change |
|---|---|---|
Revenue | 2.86M | -38.99% |
Operating expense | 8.64M | -29.12% |
Net income | -8.04M | 17.91% |
Net profit margin | -280.75 | -34.55% |
Earnings per share | — | — |
EBITDA | -7.63M | 24.04% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Nov 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 34.12M | -15.60% |
Total assets | 69.31M | -14.66% |
Total liabilities | 9.75M | -36.20% |
Total equity | 59.56M | — |
Shares outstanding | — | — |
Price to book | — | — |
Return on assets | -27.50% | — |
Return on capital | -32.57% | — |
Cash Flow
Net change in cash
| (SEK) | Nov 2024info | Y/Y change |
|---|---|---|
Net income | -8.04M | 17.91% |
Cash from operations | -12.82M | -28.77% |
Cash from investing | -5.00K | 88.48% |
Cash from financing | 161.96K | -60.09% |
Net change in cash | -12.67M | -32.00% |
Free cash flow | -9.96M | -51.86% |
About
Founded
2014
Website
Employees
24
